pneumonia

Moxifloxacin is a new broad spectrum 8-meth-oxiquinolon with high activity against both Gram(+) and Gram(–) microorganisms as well as against anaerobes and intracellular pathogens. It is also active against microorganisms that are resistant to other …

In the present review the analysis of the efficacy and appropriateness of the use of non-antimicrobial medications in the treatment of community-acquired pneumonia is presented. It is shown, that at the present time there is no convincing data that …

The present guidelines for clinical practice suggest preferable approaches to the problem of antibacterial therapy pneumonia in children. Сlassification of pneumonia, risk factors, current data on aetiology and antimicrobial resistance of respiratory …